Bortrac 2 Bortezomib Injection IP 2mg
Bortrac 2 Bortezomib Injection IP 2mg

Bortrac 2 Bortezomib Injection IP 2mg

MOQ : 10 Pieces

Bortrac 2 Bortezomib Injection IP 2mg Specification

  • Salt Composition
  • Bortezomib
  • Dosage Form
  • Injection
  • Indication
  • For Multiple Myeloma and Mantle Cell Lymphoma
  • Feature
  • Single use vial, sterile preparation
  • Ingredients
  • Bortezomib 2mg
  • Application
  • Cancer Treatment
  • Physical Color/Texture
  • Lyophilized Powder
  • Storage Instructions
  • Store below 25C, protect from light
  • Shelf Life
  • 24 Months
  • Prescription Required
  • Yes
  • Strength
  • 2 mg
  • Marketed In
  • Internationally (Canada, EU, UK, USA, Australia)
  • Brand Name
  • Bortrac-2
  • Administration Route
  • For Intravenous or Subcutaneous Use
  • Pack Size
  • Single vial
  • Packaging Type
  • Vial
  • Formulation
  • Lyophilized
  • Usage
  • Hospital, Clinical
 
 

Bortrac 2 Bortezomib Injection IP 2mg About



Grab the illustrious Bortrac-2 Bortezomib Injection IP 2mg, a hot-selling, top-notch product renowned internationally for its wondrous efficacy. Formulated as a lyophilized powder and supplied in a single-use sterile vial, this scarce medication is vital in the treatment of Multiple Myeloma and Mantle Cell Lymphoma. Engineered for both intravenous and subcutaneous use under prescription, Bortrac-2 embodies excellence in cancer therapeutics. Trusted by hospitals and clinics in Canada, the EU, UK, USA, and Australia, Bortrac-2 delivers reliability and confidence for demanding oncology protocols.

Broad Application and Versatility in Cancer Care

Bortrac-2 Bortezomib Injection IP 2mg is specifically designed for the treatment of Multiple Myeloma and Mantle Cell Lymphoma, making it a staple in oncological therapy. Suitable for hospital and clinical environments, this injection caters to both specific and general applications in cancer management. Commercially, it is sought after by healthcare providers and suppliers involved in comprehensive cancer treatment, confirming its versatile role in professional medical settings.


Certifications, Robust Supply Ability, and Export Expertise

Bortrac-2 Bortezomib Injection IP 2mg boasts global certifications, meeting rigorous international standards for safety and efficacy. With quick dispatch and reliable supply, this medication is readily available for both domestic and international markets. The manufacturer's capability ensures consistent accessibility, making Bortrac-2 a trusted choice for main export markets including Canada, Europe, the UK, USA, and Australia, as well as robust coverage in the domestic segment.


FAQ's of Bortrac 2 Bortezomib Injection IP 2mg:


Q: How is Bortrac-2 Bortezomib Injection administered?

A: Bortrac-2 is administered either intravenously or subcutaneously by a qualified healthcare professional in clinical or hospital settings.

Q: What are the primary indications for using Bortrac-2?

A: Bortrac-2 is indicated for the treatment of Multiple Myeloma and Mantle Cell Lymphoma as part of a comprehensive cancer management protocol.

Q: Where can Bortrac-2 Bortezomib Injection be supplied?

A: It is marketed internationally, with major export markets including Canada, the European Union, UK, USA, Australia, and is also available domestically in India.

Q: What is the process for storage and handling of Bortrac-2?

A: Bortrac-2 should be stored below 25C, protected from light, and handled as a single-use, sterile vial to ensure safety and efficacy.

Q: What benefits does Bortrac-2 offer over other cancer treatments?

A: Bortrac-2 provides a top-notch, sterile formulation with global certifications, ensuring reliable and efficient management of specific blood cancers with quick supply and dispatch.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Medicines Category

Gliotem Temozolomide 20mg Capsules

Gliotem Temozolomide 20mg Capsules

Minimum Order Quantity : 10 Pieces

Ingredients : Other , Temozolomide and excipients

Indication : Treatment of certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma

Storage Instructions : Store below 25C in a dry place, protect from light

Shelf Life : As indicated on packaging, generally 23 years

Physical Color/Texture : Other , Solid oral capsule

Abiraterone Acetate Arbitus Tablet 250mg

Abiraterone Acetate Arbitus Tablet 250mg

Minimum Order Quantity : 10 Packs

Ingredients : Other , Abiraterone Acetate, Excipients

Indication : Prostate cancer treatment

Storage Instructions : Store below 30C, protect from moisture and light

Shelf Life : 24 months

Physical Color/Texture : Other , Filmcoated tablet

Temonat Temozolomide 20mg Capsule

Temonat Temozolomide 20mg Capsule

Minimum Order Quantity : 10 Packs

Ingredients : Other , Temozolomide and excipients

Indication : Used in the treatment of certain types of brain tumors such as glioblastoma multiforme and anaplastic astrocytoma

Storage Instructions : Store below 25C; keep in original container to protect from moisture

Shelf Life : Check package for expiry date; generally 2436 months from manufacture

Physical Color/Texture : Other , Capsule form

Dexamethasone Decmax 4mg Tablet

Dexamethasone Decmax 4mg Tablet

Minimum Order Quantity : 10 Pieces

Ingredients : Other , Dexamethasone and excipients

Indication : Used to treat inflammation, allergic reactions, certain forms of arthritis, skin, blood, kidney, eye, thyroid, and intestinal disorders, severe allergies, and asthma. Also used as part of treatment for certain types of cancer.

Storage Instructions : Store in a cool, dry place below 30C. Keep away from moisture and sunlight.

Shelf Life : 24 months from manufacturing date

Physical Color/Texture : Other , White tablets



Back to top